Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2018

01-06-2018 | Research Article

Doctors and pharmacists provision and opinions of medicines information leaflets in New Zealand

Authors: Amber Young, June Tordoff, Sharon Leitch, Alesha Smith

Published in: International Journal of Clinical Pharmacy | Issue 3/2018

Login to get access

Abstract

Background Providing verbal medicines information to patients may be insufficient. Providing medicine information leaflets could support verbal information, however New Zealand health professionals’ opinions or use of leaflets is unknown. Objective To examine self-reported provision and health professionals’ views about medicine information leaflets and to determine their support for tailoring patient leaflets. Setting A cross sectional survey of general practitioners (GPs) and community pharmacists in New Zealand primary care. Method GPs and pharmacists completed validated questionnaires. Data was collected using SurveyMonkey® and where applicable, Chi squared analysis was carried out. Main outcome measures Frequency of leaflet provision, how leaflets are used in practice and why, likes and dislikes of available leaflets, and opinions on providing tailored information. Results 143 GPs and 126 pharmacists responded. For new medicines, significantly more pharmacists than GPs reported providing leaflets all or most of the time. For repeat medicines, leaflets were more likely to be given only on request. Leaflets were given to ensure patients are well-informed. Most GPs and pharmacists report discussing sections of leaflets with patients. The likes and dislikes of leaflets were mostly about design and content. Both professions support tailoring leaflets to meet individual’s requirements. Conclusions Provision of medicines information needs to be re-evaluated. Relying on verbal communication is inadequate and leaflet provision appears to be suboptimal. Making leaflets more patient-centred and accessible could improve health professionals’ perceptions and use of them. Automated creation and provision of tailored summary leaflets would be beneficial. Further advantage could be gained by digital patient access.
Appendix
Available only for authorised users
Literature
2.
go back to reference Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783–801.CrossRefPubMed Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783–801.CrossRefPubMed
4.
go back to reference Koo MM, Krass I, Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother. 2003;37(2):259–67.CrossRefPubMed Koo MM, Krass I, Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother. 2003;37(2):259–67.CrossRefPubMed
7.
go back to reference Aslani P, Hamrosi K, Feletto E. Investigating consumer medicine information (CMI) report. CMI effectiveness tender Canberra: The Pharmacy Guild of Australia and Department of Health and Ageing; 2010. Aslani P, Hamrosi K, Feletto E. Investigating consumer medicine information (CMI) report. CMI effectiveness tender Canberra: The Pharmacy Guild of Australia and Department of Health and Ageing; 2010.
8.
go back to reference Sadowski CA. Providing health information to older adults. Rev Clin Gerontol. 2011;21(01):55–66.CrossRef Sadowski CA. Providing health information to older adults. Rev Clin Gerontol. 2011;21(01):55–66.CrossRef
12.
go back to reference Raynor D, Blenkinsopp A, Knapp P, Grime J, Nicolson D, Pollock K, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):1–178. https://doi.org/10.3310/hta11050.CrossRef Raynor D, Blenkinsopp A, Knapp P, Grime J, Nicolson D, Pollock K, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):1–178. https://​doi.​org/​10.​3310/​hta11050.CrossRef
22.
go back to reference Jaye C, Hope J, Martin IR. What do general practice patients know about their prescription medications. NZ Med J. 2002;115(1162):U183. Jaye C, Hope J, Martin IR. What do general practice patients know about their prescription medications. NZ Med J. 2002;115(1162):U183.
24.
go back to reference Bandesha G, Raynor DK, Teale C. Preliminary investigation of patient information leaflets as package inserts. Int J Pharm Pract. 1996;4(4):246–8.CrossRef Bandesha G, Raynor DK, Teale C. Preliminary investigation of patient information leaflets as package inserts. Int J Pharm Pract. 1996;4(4):246–8.CrossRef
30.
go back to reference Field A. Discovering statistics using IBM SPSS statistics. 4th ed. Thousand Oaks: Sage; 2013. Field A. Discovering statistics using IBM SPSS statistics. 4th ed. Thousand Oaks: Sage; 2013.
32.
go back to reference Javadi M, Zarea K. Understanding thematic analysis and its pitfall. J Client Care. 2016;1(1):33–9. Javadi M, Zarea K. Understanding thematic analysis and its pitfall. J Client Care. 2016;1(1):33–9.
34.
go back to reference Raynor D, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J. 2000;264(7083):268–70. Raynor D, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J. 2000;264(7083):268–70.
40.
41.
go back to reference Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007;26(3):731–40.CrossRef Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007;26(3):731–40.CrossRef
Metadata
Title
Doctors and pharmacists provision and opinions of medicines information leaflets in New Zealand
Authors
Amber Young
June Tordoff
Sharon Leitch
Alesha Smith
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0635-7

Other articles of this Issue 3/2018

International Journal of Clinical Pharmacy 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine